INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Early-Stage Biotech's AI Advantage Is A Window That Closes

  The "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.

• Why Open API Architecture Matters In Clinical Research

  Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.

• On-site ePRO Solutions For Flexible Data Collection Across Devices

  Optimize flexible electronic patient-reported outcomes that allow participants to switch between site-owned devices, personal hardware, and remote completion.

• Rethinking Technology For Patients And Sites In Clinical Trials

  The solution to administrative burden in clinical trials is not in adding more tools, but in improved integration that allows software to fade into the background.

• Solving Key eCOA Challenges Through Digital Trials—Proof Points!

  1/14/2025

  Medable has reached some important milestones and shares them in its end-of-year report. Check it out to see what game-changing results they've brought to their customers.

• The Strategic Backbone Of Marketing Application Success

  3/12/2025

  Through proactive timeline management and strategic oversight, organizations can achieve their regulatory goals with confidence.

• Build Vs. Buy Vs. Partner In Life Sciences: Making The Right Call

  3/21/2025

  Discover when life sciences organizations should develop technology in-house, buy off-the-shelf solutions, or form strategic partnerships, exploring the costs and risks that come with each approach.

• Driving A High-Adherence LTFU Trial Without An EDC

  10/29/2025

  Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.

• Develop A Comprehensive Strategy For Implementing AI & Multi-Omics

  2/19/2026

  Discover how a strategy-first approach to AI and multi-omics transforms complex biological data into actionable clinical decisions and more precise, targeted oncology therapies for 2026 and beyond.